Jeremy Abramson, MD, MMSc

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Genentech
    Topic: 
    lymphoma
    Date added: 
    01/16/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    BMS
    Topic: 
    lymphoma
    Date added: 
    01/16/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Gilead
    Topic: 
    lymphoma
    Date added: 
    01/16/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Seagen
    Topic: 
    lymphoma
    Date added: 
    01/16/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Interius
    Topic: 
    lymphoma
    Date added: 
    01/16/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    AbbVie
    Topic: 
    lymphoma
    Date added: 
    01/16/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    BeiGene
    Topic: 
    lymphoma
    Date added: 
    01/16/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Lilly
    Topic: 
    lymphoma
    Date added: 
    01/16/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Cellectar
    Topic: 
    lymphoma
    Date added: 
    01/16/2024
    Relationship end date: 
    02/17/2023
Return to Upstate New York Hematology & Hematologic Oncology Conference: Updates from the 65th ASH Annual Meeting